Yesterday’s New York Times article about health care reform and the overly inflated cost of the American health care system should ring large and loud alarm bells in the prostate cancer community. This article, along with the recent increasing pressure to halt prostate cancer screening, should put a major scare into the community. Unfortunately, the [...]
The FDA did introduce its Critical Path initiative in 2004. But, even these expedited processes have become bogged down. The FDA has responded to the political winds and become cautious after the negative publicity it received from the withdrawals of drugs like Rezulin and Vioxx. The best and most recent delay in the prostate cancer [...]
Please take a few minutes to help elevate OUR prostate cancer nonprofit, Malecare. As you know, Malecare started and facilitate this blog as part of our program addressing the needs of men living with advanced prostate cancer. Though Malecare is known as our country's leading gay men's cancer support group nonprofit, we are committed to [...]
Senator Arlen Specter (D-PA) introduced S. 914, the Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009. The bill has three main components: 1. Establishes a new, independent federal agency, to be known as the “Cures Acceleration Network” (CAN), which would award grants and contracts to accelerate the development of cures and [...]
Why do we need an Office of Men’s Health and why do we need more emphasize put on men’s health awareness? Studies like this one in the UK answer these simple questions: A recent study published this week by the National Cancer Intelligence Network (NCIN) and Cancer Research UK, concluded that men are almost 40 [...]
The fairness of increasing cancer research funding in FY2010 comes into question during House and Senate hearings. See my post of May 23, 2009: Senator Harkin and the Senate Appropriations subcommittee on Labor, Health and Human Services, and Education Hold Hearings on the Budget Allocations to the NCI for Cancer Research Two leading appropriators in [...]
On Thursday the Senate Appropriations subcommittee on Labor, Health and Human Services, and Education held its FY 2010 NIH budget hearing. There were two particular items of note for the cancer community. When discussing the NIH funding which was received through the economic stimulus package, Senator Harkin questioned if the current two years the NIH [...]
Getting increased funding for the Department of Defense (DOD) Peer Review Prostate Cancer Research Program (PCRP) is one of the goals that have been identified by a coalition of many of the prostate cancer advocacy and support organizations. The funding for the program has remained stagnant for a number of years despite the fact that [...]
I have been talking about the need to increase the funding levels for the Department of Defense (DOD) Peer Review Prostate Cancer Research Program (PCRP) for a long period. This program has proven itself to be the single most valuable government funded prostate cancer research program. The program is designed to fund research projects that [...]
Shocking news, under the President Obama's latest budget request, the prostate cancer program at CDC would receive only a 0.23% increase. The FDA would receive an appropriation of $2.35 billion, an increase of $295 million (14.4%), once again prostate cancer has been left in the dust! Joel T Nowak MA, MSW
